What is your brain tumor story? Click here to share it. Your story matters.
Sign up for our bi-monthly email to get the latest news on treatments, support, and stories from the brain tumor community.
Featured Clinical Study A Dose Escalation and Expansion Study of Sonodynamic Therapy With SONALA-001 in Combination With Exablate 4000 Type-2 MR-guided Focused Ultrasound in Patients With Recurrent or Progressive Glioblastoma
Featured Clinical Study A Feasibility Study to Evaluate the Safety of the TheraSphere Glioblastoma (GBM) Device in Patients With Recurrent GBM (FRONTIER) Study Sponsor: Boston Scientific Study website: Frontier Study
Study to Evaluate the Safety, Tolerability, and Optimal Dose of Candidate GBM Vaccine VBl-1901 in Recurrent GBM Subjects Featured Clinical Study Study to Evaluate the Safety, Tolerability, and Optimal Dose
Study of Tirabrutinib (ONO-4059) in Patients With Primary Central Nervous System Lymphoma (PROSPECT Study).
Jean Arzbaecher is an advanced practice nurse working as a clinical nurse specialist in neuro-oncology at the University of Illinois Brain Tumor Center. Jean has spent her entire career in
Shanu Khanuja currently works within the biotech industry and serves in commercial roles that continue to bring to light the patient journey. She was a caregiver to her mother who
Meet the recipients of the ABTA’s highest honors and learn how they’re making a difference.
Meet two researchers on opposite ends of the globe dedicated to transforming the future of brain tumor treatments.
Read our top takeaways from the Society for Neuro-Oncology (SNO) Annual Meeting, the world’s largest gathering of neuro-oncology experts.
Always free for patients & caregivers
